🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What a wonderful space for trainees and early career faculty at #ASCO25 Check it out in Hall C Hem-Onc Fellows Network ASCO TECAG

⭐️We’re kicking off the #ASCO25 IMG CoP Meeting with opening remarks by Ziad Bakouny, MD, MSc and Nazli Dizman!! Come join us in room S103! #IMGCoP ASCO ASCO TECAG OncoAlert

🌎 International Medical Graduates Community of Practice 🌎 #ASCO25 🧑‍⚕️ 37.1% of #HemeOnc physicians in the USA are IMGs 🩺 IMGs are absolutely VITAL to the oncology workforce bringing #excellence #innovation #grit #diversity 👥 IMGs often encounter unique challenges that can

🌟 Dr. Xia (Yaya) Wu is presenting their work on visa sponsorship for #IMGs in #oncology at #ASCO25 #IMGoncCoP meeting!! Join us to hear more! ASCO OncoAlert ASCO TECAG

🚨Noha N. Soror, MD, MSc. 𓂀 is presenting now our new Mentorship & Sponsorship committee!! #ASCO25 #IMGoncCoP Very exciting initiatives for upcoming #HemOnc fellowship applicants!! Join us in room S103!! ASCO ASCO TECAG OncoAlert Hem-Onc Fellows Network Oncology Brothers

📣 Join us Monday at 2PM at the JCO Central Lounge! We’ll be sharing insights from the JCO OP Editorial Fellowship with Dr. Raghavan and @YenongCao — from how to write strong peer reviews to navigating the publishing process. Don’t miss it! 🔗 dailynews.ascopubs.org/do/jco-central… #ASCO25 #JCO

Taking my little one to her first ASCO meeting #ASCO25 ASCO #BabyOlivia

Awesome gathering of Dartmouth Cancer Center people #ASCO25 Always good vibes and great convos. #Dartmouth #BigGreenFam

🎖️Day 2 of #ASCO25 at ASCO TECAG lounge with a full agenda! ASCO ✨Come join us for excellent panels, networking opportunities, one-on-one mentorship and to relax, recharge and grab snacks & coffee! Agenda 👉cdn.bfldr.com/KOIHB2Q3/as/7c… #MedEd Rami Manochakian MD, FASCO Cancer Education Nazli Dizman

🎖️ASCO TECAG #ASCO25 #Trainees learn #advocacy early! "Advocacy 101: How to Make a Difference for Your Patients and Your Practice" with Christine Hodgdon #DrBrianPersing Ivy Riano, M.D. Jasmine Kamboj, MD, FASCO ⏰5/31 12:30 PM - 1:15 PM📌 Hall C #OncMedEdCoP ASCO Hem-Onc Fellows Network

In 2020 Dr. Rodriguez messaged me “We need a dedicated Latinas in Oncology YIA - let’s fundraise” 5 yrs later and thanks to many of you we have funded 5 Latinas YIAs I hope changes in administration don’t kill this beautiful initiate - A grassroots fundraising effort to

An honor to be a Fellow of ASCO and celebrate with so many colleagues, friends, and people I admire at #ASCO25 UCSF Helen Diller Family Comprehensive Cancer Ctr

We had a great panel today—diverse perspectives and fantastic questions from our trainees! #Advocacy #ASCO25 ASCO cc Andrew P. Loehrer

Fantastic representation of #Thoracic oncology ASCO #ASCO25 posters! Ben Bleiberg Melina Marmarelis Corey Langer Lova Sun Penn Medicine - Abramson Cancer Center Penn Medicine MD Penn Medicine

Congratulations to my dear sister friend, Ana I. Velázquez Mañana, MD, MSc, FASCO on becoming FASCO so early in her career!! A consummate leader, clinical investigator, advocate, and mentor!! 🤩 ASCO Nazli Dizman UCSF Helen Diller Family Comprehensive Cancer Ctr Terry Friedlander Sumanta K. Pal, MD, FASCO Petros Grivas

Join us at ASCO’s Women Networking Center for Balancing Life, Work, and Combatting #Burnout: Perspectives from #WomeninOncology with Drs. Clara Hwang, Christine Brezden-Masley, and Dame Idossa 📍S502 #ASCO25 #WomenInMedicine

Ivy Riano, M.D. ASCO Andrew P. Loehrer Excited to see all the interest in advocacy in trainees and early career oncology professionals. In my experience, weaving advocacy into the fabric of your career keeps you and your patients from unraveling.

Today is your day dear Ana I. Velázquez Mañana, MD, MSc, FASCO ! You’ve officially become a FASCO at such an early stage in your career, and now you’re ending the day with well-deserved recognition for advancing equity in cancer care. Congratulations! I'm proud to call you my friend

🫁 #LungCancer Oral Abstract Session #ASCO25 KRYSTAL-7: 1L adagrasib + pembrolizumab in metastatic KRASG12C NSCLC 🔹ORR 44% (ORR 36% for PD-L1 <1%) 🔹mPFS 11 mo 🔹mOS 18.3 mo, similar across PD-L1 subgroups 🔹11-14% G3+ LFT elevations #LCSM KRASKickers

💫ASCO #ASCO25 #IMGoncCOP meeting was so genuine, collaborative, and uplifting! 💎With >200 attendees and 20 presenters, we came together to share real experiences, emotional and logistical burdens of moving from abroad, guided the next generation on tackling challenges, and